VANCOUVER, British Columbia, Dec. 15, 2023 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced it is expected to be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the “NBI”). Zymeworks’ addition to the NBI will become effective prior to the market open on Monday, December 18, [...]
Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships DURHAM, N.C., Dec. 13, 2023 (Korea Bizwire) – Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it convened last week the inaugural meeting of its Site Advisory Board, a collaboration between clinical research investigator [...]
Wandercraft unveils a groundbreaking innovation, its self-stabilizing Personal Exoskeleton, at an exclusive event in New York Exclusive in-person and virtual event today (link below) will reveal a groundbreaking innovation in robotics engineering from Wandercraft ahead of product finalization and market launch Once cleared, the Personal Exoskeleton could be the first and only self-stabilizing walk exoskeleton [...]
Novel Non-surgical Intradermal Treatment for Basel Cell Carcinoma COSA MESA, Calif., Dec. 11, 2023 (Korea Bizwire) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced completion of their first trial administering AIV001 (axitinib) to patients diagnosed with basal cell carcinoma (BCC) tumors. AIV001 is AiViva’s novel intradermally administered product designed for local, prolonged treatment effect [...]
London, Dec. 11, 2023 (Korea Bizwire) – London, UK – December 11, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is excited to announce a strategic collaboration with Nested Knowledge, a leading provider of AI-based SaaS platform solutions for systematic literature review and meta-analysis. Together, [...]
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio® Data presented at the DGSM Conference in Berlin by Dr. Christian Plettenberg on December 8, 2023 Results showed an average AHI decrease of 73% Mont-Saint-Guibert, Belgium – December 11, 2023, 7:30am CET / 1:30am ET (Korea Bizwire) – Nyxoah SA (Euronext [...]
REGULATED INFORMATION Publication Relating to a Transparency Notification Mont-Saint-Guibert (Belgium), December 8, 2023, 10.30pm CET / 4.30pm ET (Korea Bizwire) – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below. On December 6, 2023, Nyxoah received a transparency [...]
KIGALI, Rwanda, Dec. 05, 2023 (Korea Bizwire) – The 13th International Conference on Typhoid & Other Invasive Salmonelloses gets under way today in Kigali, Rwanda, with nearly 350 researchers, healthcare professionals and policymakers meeting to find ways to address the urgent challenges of typhoid and other invasive salmonelloses. The three-day conference, hosted by the Coalition against [...]
ALBANY, N.Y., Dec. 05, 2023 (Korea Bizwire) – Curia, a leading contract research, development and manufacturing organization, today announced it has been recognized as one of the top 10 CDMOs in India by India Pharma Outlook. The full list can be viewed in the November 2023 edition of the India Pharma Outlook magazine. This recognition acknowledges [...]
With its targeted multimodal approach, NeuroAiD™II offers a broad range of therapeutic benefits to TBI patients. NeuroAiD™II was well-tolerated by TBI patients with a favourable safety profile. SINGAPORE, Dec. 04, 2023 (Korea Bizwire) – Moleac announced promising results from the SAMURAI double-blind study in patients with mild traumatic brain injury (mTBI) receiving a 6-month course [...]